260 related articles for article (PubMed ID: 21346069)
1. A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A.
Le Dour C; Schneebeli S; Bakiri F; Darcel F; Jacquemont ML; Maubert MA; Auclair M; Jeziorowska D; Reznik Y; Béréziat V; Capeau J; Lascols O; Vigouroux C
J Clin Endocrinol Metab; 2011 May; 96(5):E856-62. PubMed ID: 21346069
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and cardiac phenotype characterization in 37 atypical Dunnigan patients with nonfarnesylated mutated prelamin A.
Andre P; Schneebeli S; Vigouroux C; Lascols O; Schaaf M; Chevalier P
Am Heart J; 2015 Apr; 169(4):587-93. PubMed ID: 25819867
[TBL] [Abstract][Full Text] [Related]
3. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.
Caron M; Auclair M; Donadille B; Béréziat V; Guerci B; Laville M; Narbonne H; Bodemer C; Lascols O; Capeau J; Vigouroux C
Cell Death Differ; 2007 Oct; 14(10):1759-67. PubMed ID: 17612587
[TBL] [Abstract][Full Text] [Related]
4. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
5. LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation.
Afonso P; Auclair M; Boccara F; Vantyghem MC; Katlama C; Capeau J; Vigouroux C; Caron-Debarle M
Atherosclerosis; 2016 Feb; 245():200-11. PubMed ID: 26724531
[TBL] [Abstract][Full Text] [Related]
6. Nuclear envelope-related lipodystrophies.
Guénantin AC; Briand N; Bidault G; Afonso P; Béréziat V; Vatier C; Lascols O; Caron-Debarle M; Capeau J; Vigouroux C
Semin Cell Dev Biol; 2014 May; 29():148-57. PubMed ID: 24384368
[TBL] [Abstract][Full Text] [Related]
7. LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations.
Bidault G; Vatier C; Capeau J; Vigouroux C; Béréziat V
Biochem Soc Trans; 2011 Dec; 39(6):1752-7. PubMed ID: 22103520
[TBL] [Abstract][Full Text] [Related]
8. Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome.
Donadille B; D'Anella P; Auclair M; Uhrhammer N; Sorel M; Grigorescu R; Ouzounian S; Cambonie G; Boulot P; Laforêt P; Carbonne B; Christin-Maitre S; Bignon YJ; Vigouroux C
Orphanet J Rare Dis; 2013 Jul; 8():106. PubMed ID: 23849162
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation.
Verstraeten VL; Broers JL; van Steensel MA; Zinn-Justin S; Ramaekers FC; Steijlen PM; Kamps M; Kuijpers HJ; Merckx D; Smeets HJ; Hennekam RC; Marcelis CL; van den Wijngaard A
Hum Mol Genet; 2006 Aug; 15(16):2509-22. PubMed ID: 16825282
[TBL] [Abstract][Full Text] [Related]
10. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
[TBL] [Abstract][Full Text] [Related]
11. Severe mandibuloacral dysplasia-associated lipodystrophy and progeria in a young girl with a novel homozygous Arg527Cys LMNA mutation.
Agarwal AK; Kazachkova I; Ten S; Garg A
J Clin Endocrinol Metab; 2008 Dec; 93(12):4617-23. PubMed ID: 18796515
[TBL] [Abstract][Full Text] [Related]
12. The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B.
Odinammadu KO; Shilagardi K; Tuminelli K; Judge DP; Gordon LB; Michaelis S
Nucleus; 2023 Dec; 14(1):2288476. PubMed ID: 38050983
[TBL] [Abstract][Full Text] [Related]
13. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
14. An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria.
Davies BS; Barnes RH; Tu Y; Ren S; Andres DA; Spielmann HP; Lammerding J; Wang Y; Young SG; Fong LG
Hum Mol Genet; 2010 Jul; 19(13):2682-94. PubMed ID: 20421363
[TBL] [Abstract][Full Text] [Related]
15. Investigating the purpose of prelamin A processing.
Davies BS; Coffinier C; Yang SH; Barnes RH; Jung HJ; Young SG; Fong LG
Nucleus; 2011; 2(1):4-9. PubMed ID: 21647293
[TBL] [Abstract][Full Text] [Related]
16. Emerin-prelamin A interplay in human fibroblasts.
Capanni C; Del Coco R; Mattioli E; Camozzi D; Columbaro M; Schena E; Merlini L; Squarzoni S; Maraldi NM; Lattanzi G
Biol Cell; 2009 Sep; 101(9):541-54. PubMed ID: 19323649
[TBL] [Abstract][Full Text] [Related]
17. Laminopathy-inducing mutations reduce nuclear import of expressed prelamin A.
Kiel T; Busch A; Meyer-Rachner A; Hübner S
Int J Biochem Cell Biol; 2014 Aug; 53():271-80. PubMed ID: 24943589
[TBL] [Abstract][Full Text] [Related]
18. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy.
Caux F; Dubosclard E; Lascols O; Buendia B; Chazouillères O; Cohen A; Courvalin JC; Laroche L; Capeau J; Vigouroux C; Christin-Maitre S
J Clin Endocrinol Metab; 2003 Mar; 88(3):1006-13. PubMed ID: 12629077
[TBL] [Abstract][Full Text] [Related]
19. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
Decaudain A; Vantyghem MC; Guerci B; Hécart AC; Auclair M; Reznik Y; Narbonne H; Ducluzeau PH; Donadille B; Lebbé C; Béréziat V; Capeau J; Lascols O; Vigouroux C
J Clin Endocrinol Metab; 2007 Dec; 92(12):4835-44. PubMed ID: 17711925
[TBL] [Abstract][Full Text] [Related]
20. Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation.
Ben Yaou R; Navarro C; Quijano-Roy S; Bertrand AT; Massart C; De Sandre-Giovannoli A; Cadiñanos J; Mamchaoui K; Butler-Browne G; Estournet B; Richard P; Barois A; Lévy N; Bonne G
Eur J Hum Genet; 2011 Jun; 19(6):647-54. PubMed ID: 21267004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
